| (S)-amphetamine | increases expression | ISO | RGD:733443 | 6480464 | Dextroamphetamine results in increased expression of CCND3 mRNA | CTD | PMID:12558987 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:733443 | 6480464 | Ethinyl Estradiol affects the expression of CCND3 mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:733443 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CCND3 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:733443 | 6480464 | Ethinyl Estradiol results in increased expression of CCND3 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of CCND3 mRNA | CTD | PMID:15897899 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of CCND3 mRNA | CTD | PMID:15897899 PMID:17622325 |
| 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of CCND3 mRNA | CTD | PMID:21826169 PMID:22574217 |
| 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of CCND3 mRNA | CTD | PMID:21826169 |
| 17beta-estradiol | increases expression | ISO | RGD:733443 | 6480464 | Estradiol results in increased expression of CCND3 mRNA | CTD | PMID:11861973 |
| 17beta-estradiol | affects expression | ISO | RGD:733443 | 6480464 | Estradiol affects the expression of CCND3 mRNA | CTD | PMID:9094091 |
| 17beta-estradiol | multiple interactions | ISO | RGD:733443 | 6480464 | Cycloheximide affects the reaction [Estradiol affects the expression of CCND3 mRNA]; more ... | CTD | PMID:9094091 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:733443 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CCND3 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:733443 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CCND3 mRNA | CTD | PMID:18343893 PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:733443 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CCND3 mRNA | CTD | PMID:21041162 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733443 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCND3 mRNA | CTD | PMID:17942748 PMID:15328365 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733443 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCND3 mRNA | CTD | PMID:15328365 PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:733443 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CCND3 mRNA | CTD | PMID:18343893 |
| 2-methoxyethanol | affects expression | ISO | RGD:2293 | 6480464 | methyl cellosolve affects the expression of CCND3 mRNA | CTD | PMID:19643169 |
| 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:733443 | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of CCND3 mRNA | CTD | PMID:18648102 |
| 5-fluorouracil | affects response to substance | EXP | | 6480464 | CCND3 affects the susceptibility to Fluorouracil | CTD | PMID:15067352 |
| 5-fluorouracil | affects response to substance | EXP | | 6480464 | CCND3 protein affects the susceptibility to Fluorouracil | CTD | PMID:15548681 PMID:18383818 |
| 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of CCND3 mRNA | CTD | PMID:16709241 |
| 5-fluorouracil | affects response to substance | EXP | | 6480464 | CCND3 protein affects the susceptibility to Fluorouracil | CTD | PMID:18383818 PMID:15548681 |
| 9-cis-retinoic acid | decreases expression | EXP | | 6480464 | alitretinoin results in decreased expression of CCND3 protein | CTD | PMID:16273314 |
| acetylleucyl-leucyl-norleucinal | multiple interactions | EXP | | 6480464 | acetylleucyl-leucyl-norleucinal inhibits the reaction [Tretinoin results in increased degradation of and results in decreased expression of CCND3 protein] | CTD | PMID:16024653 |
| acetylsalicylic acid | multiple interactions | EXP | | 6480464 | Aspirin promotes the reaction [troglitazone results in decreased expression of CCND3 protein]; more ... | CTD | PMID:19908241 |
| acetylsalicylic acid | decreases expression | EXP | | 6480464 | Aspirin results in decreased expression of CCND3 protein | CTD | PMID:19908241 |
| acetylsalicylic acid | decreases expression | EXP | | 6480464 | Aspirin results in decreased expression of CCND3 mRNA | CTD | PMID:14976132 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of CCND3 mRNA | CTD | PMID:22100608 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Tretinoin promotes the reaction [CPG-oligonucleotide results in increased expression of CCND3 protein]]; more ... | CTD | PMID:17209053 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CCND3 protein | CTD | PMID:16920920 PMID:20507312 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:2293 | 6480464 | Tretinoin results in decreased expression of CCND3 protein | CTD | PMID:11675954 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:2293 | 6480464 | Tretinoin inhibits the reaction [FGF2 protein results in increased expression of CCND3 mRNA] | CTD | PMID:11675954 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CCND3 protein | CTD | PMID:20507312 PMID:16920920 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:733443 | 6480464 | Tretinoin results in decreased expression of CCND3 mRNA | CTD | PMID:16604517 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CCND3 mRNA | CTD | PMID:16920920 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCND3 protein] | CTD | PMID:12421932 |
| all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of CCND3 mRNA | CTD | PMID:16024653 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Tretinoin results in increased expression of CCND3 protein] | CTD | PMID:16920920 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | acetylleucyl-leucyl-norleucinal inhibits the reaction [Tretinoin results in increased degradation of and results in decreased expression of CCND3 protein] | CTD | PMID:16024653 |
| ammonium chloride | increases expression | ISO | RGD:2293 | 6480464 | Ammonium Chloride results in increased expression of CCND3 protein | CTD | PMID:16483693 |
| aniline | increases expression | ISO | RGD:2293 | 6480464 | aniline results in increased expression of CCND3 mRNA; more ... | CTD | PMID:21070798 |
| atropine | multiple interactions | EXP | | 6480464 | [Parathion co-treated with Atropine] results in increased expression of CCND3 mRNA | CTD | PMID:17390078 |
| benzene | multiple interactions | ISO | RGD:733443 | 6480464 | TRP53 protein promotes the reaction [Benzene results in decreased expression of CCND3] | CTD | PMID:15935813 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CCND3 mRNA | CTD | PMID:21632981 |
| bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of CCND3 mRNA | CTD | PMID:21826169 |
| bisphenol A | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [bisphenol A results in increased expression of CCND3 protein] | CTD | PMID:23222814 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CCND3 protein | CTD | PMID:23222814 |
| bucladesine | increases expression | ISO | RGD:2293 | 6480464 | Bucladesine results in increased expression of CCND3 protein | CTD | PMID:16718685 |
| butan-1-ol | multiple interactions | EXP | | 6480464 | 1-Butanol inhibits the reaction [PDGFB protein results in decreased expression of CCND3 protein] | CTD | PMID:15919668 |
| butyric acid | increases expression | ISO | RGD:2293 | 6480464 | Butyric Acid results in increased expression of CCND3 mRNA | CTD | PMID:12800193 |
| cadmium dichloride | decreases expression | ISO | RGD:2293 | 6480464 | Cadmium Chloride results in decreased expression of CCND3 mRNA | CTD | PMID:18636176 |
| chloroprene | increases expression | ISO | RGD:733443 | 6480464 | Chloroprene results in increased expression of CCND3 mRNA | CTD | PMID:23125180 |
| chlorpromazine | decreases expression | EXP | | 6480464 | Chlorpromazine analog results in decreased expression of CCND3 mRNA | CTD | PMID:15924885 |
| chromium(6+) | decreases expression | ISO | RGD:2293 | 6480464 | chromium hexavalent ion results in decreased expression of CCND3 protein | CTD | PMID:21621607 |
| chromium(6+) | multiple interactions | ISO | RGD:2293 | 6480464 | Ascorbic Acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CCND3 protein] | CTD | PMID:21621607 |
| cisplatin | increases expression | ISO | RGD:733443 | 6480464 | Cisplatin results in increased expression of CCND3 mRNA | CTD | PMID:21151649 |
| clofibrate | multiple interactions | ISO | RGD:733443 | 6480464 | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CCND3 mRNA] | CTD | PMID:17585979 |
| clofibrate | increases expression | ISO | RGD:2293 | 6480464 | Clofibrate results in increased expression of CCND3 mRNA | CTD | PMID:12851107 |
| clozapine | increases expression | ISO | RGD:2293 | 6480464 | Clozapine results in increased expression of CCND3 mRNA | CTD | PMID:15860345 |
| cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of CCND3 mRNA | CTD | PMID:19376846 |
| cocaine | affects expression | ISO | RGD:2293 | 6480464 | Cocaine affects the expression of CCND3 mRNA | CTD | PMID:20187946 |
| copper atom | multiple interactions | EXP | | 6480464 | [Thiosemicarbazones binds to Copper] which results in decreased expression of CCND3 protein | CTD | PMID:20931265 |
| copper(0) | multiple interactions | EXP | | 6480464 | [Thiosemicarbazones binds to Copper] which results in decreased expression of CCND3 protein | CTD | PMID:20931265 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [bisphenol A results in increased expression of CCND3 protein] | CTD | PMID:23222814 |
| curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of CCND3 protein | CTD | PMID:23222814 |
| cycloheximide | affects expression | ISO | RGD:733443 | 6480464 | Cycloheximide affects the expression of CCND3 mRNA | CTD | PMID:9094091 |
| cycloheximide | multiple interactions | ISO | RGD:733443 | 6480464 | Cycloheximide affects the reaction [Estradiol affects the expression of CCND3 mRNA] | CTD | PMID:9094091 |
| cyclophosphamide | decreases expression | ISO | RGD:733443 | 6480464 | Cyclophosphamide results in decreased expression of CCND3 mRNA | CTD | PMID:21041162 |
| cytarabine | decreases expression | EXP | | 6480464 | Cytarabine results in decreased expression of CCND3 mRNA | CTD | PMID:21198554 |
| dasatinib (anhydrous) | decreases expression | EXP | | 6480464 | dasatinib results in decreased expression of CCND3 protein | CTD | PMID:16740687 |
| daunorubicin | increases expression | EXP | | 6480464 | Daunorubicin results in increased expression of CCND3 mRNA | CTD | PMID:12656675 |
| desferrioxamine B | decreases expression | EXP | | 6480464 | Deferoxamine results in decreased expression of CCND3 protein | CTD | PMID:11468187 |
| dexamethasone | decreases expression | ISO | RGD:733443 | 6480464 | Dexamethasone results in decreased expression of CCND3 mRNA | CTD | PMID:21041162 |
| diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of CCND3 mRNA | CTD | PMID:20458559 |
| diazoxide | increases expression | ISO | RGD:733443 | 6480464 | Isoproterenol results in increased expression of CCND3 mRNA | CTD | PMID:20003209 |
| dibutyl phthalate | decreases expression | ISO | RGD:2293 | 6480464 | Dibutyl Phthalate results in decreased expression of CCND3 mRNA | CTD | PMID:21266533 |
| dichlorine | multiple interactions | ISO | RGD:2293 | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of CCND3 mRNA | CTD | PMID:18636392 |
| diethylstilbestrol | decreases expression | ISO | RGD:733443 | 6480464 | Diethylstilbestrol results in decreased expression of CCND3 mRNA | CTD | PMID:21041162 |
| doxorubicin | multiple interactions | ISO | RGD:733443 | 6480464 | [zoledronic acid co-treated with Doxorubicin] results in decreased expression of CCND3 protein | CTD | PMID:19789217 |
| everolimus | decreases expression | EXP | | 6480464 | everolimus results in decreased expression of CCND3 protein | CTD | PMID:16856892 |
| fluoxetine | decreases expression | ISO | RGD:733443 | 6480464 | Fluoxetine results in decreased expression of CCND3 mRNA | CTD | PMID:21497159 |
| flutamide | increases expression | ISO | RGD:2293 | 6480464 | Flutamide results in increased expression of CCND3 mRNA | CTD | PMID:19299419 |
| folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of CCND3 mRNA | CTD | PMID:11723236 |
| fulvestrant | multiple interactions | ISO | RGD:733443 | 6480464 | fulvestrant inhibits the reaction [Estradiol affects the expression of CCND3 mRNA] | CTD | PMID:9094091 |
| gefitinib | decreases expression | EXP | | 6480464 | gefitinib results in decreased expression of CCND3 protein | CTD | PMID:16740687 |
| haloperidol | increases expression | ISO | RGD:2293 | 6480464 | Haloperidol results in increased expression of CCND3 mRNA | CTD | PMID:15860345 |
| hydroxyurea | increases expression | EXP | | 6480464 | Hydroxyurea results in increased expression of CCND3 protein | CTD | PMID:11468187 |
| hypochlorous acid | decreases expression | ISO | RGD:733443 | 6480464 | Hypochlorous Acid results in decreased expression of CCND3 mRNA | CTD | PMID:19376150 |
| imatinib | multiple interactions | EXP | | 6480464 | [imatinib co-treated with tetraarsenic tetrasulfide] results in decreased expression of CCND3 mRNA | CTD | PMID:19208803 |
| imatinib | multiple interactions | ISO | RGD:733443 | 6480464 | [bosutinib co-treated with imatinib] affects the localization of CCND3 protein; more ... | CTD | PMID:17129604 |
| imatinib | decreases expression | EXP | | 6480464 | imatinib results in decreased expression of CCND3 mRNA | CTD | PMID:19208803 |
| imatinib | decreases expression | EXP | | 6480464 | imatinib results in decreased expression of CCND3 protein | CTD | PMID:15100154 |
| isoprenaline | increases expression | ISO | RGD:733443 | 6480464 | Isoproterenol results in increased expression of CCND3 mRNA | CTD | PMID:20003209 |
| kinamycin F | decreases expression | EXP | | 6480464 | kinamycin F results in decreased expression of CCND3 mRNA; more ... | CTD | PMID:20079721 |
| L-ascorbic acid | multiple interactions | ISO | RGD:2293 | 6480464 | Ascorbic Acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CCND3 protein] | CTD | PMID:21621607 |
| lovastatin | decreases expression | EXP | | 6480464 | Lovastatin results in decreased expression of CCND3 protein | CTD | PMID:10502407 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [IL2 protein results in increased expression of CCND3 mRNA]; more ... | CTD | PMID:15778701 |
| LY294002 | decreases expression | ISO | RGD:733443 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of CCND3 protein | CTD | PMID:15601625 |
| LY294002 | decreases expression | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of CCND3 protein | CTD | PMID:14757120 |
| lycorine | decreases expression | EXP | | 6480464 | lycorine results in decreased expression of CCND3 mRNA | CTD | PMID:23376478 |
| methylazoxymethanol | increases expression | ISO | RGD:733443 | 6480464 | methylazoxymethanol results in increased expression of CCND3 mRNA | CTD | PMID:17107856 |
| methylmercury chloride | decreases expression | ISO | RGD:733443 | 6480464 | methylmercuric chloride results in decreased expression of CCND3 mRNA | CTD | PMID:20061341 |
| methylmercury chloride | decreases expression | ISO | RGD:2293 | 6480464 | methylmercuric chloride results in decreased expression of CCND3 protein | CTD | PMID:17760861 |
| N-methyl-N-nitrosurea | increases expression | ISO | RGD:2293 | 6480464 | Methylnitrosourea results in increased expression of CCND3 protein | CTD | PMID:18155124 |
| ozone | multiple interactions | ISO | RGD:2293 | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of CCND3 mRNA | CTD | PMID:18636392 |
| paracetamol | multiple interactions | ISO | RGD:733443 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of CCND3 mRNA; more ... | CTD | PMID:17585979 |
| paraquat | decreases expression | ISO | RGD:2293 | 6480464 | Paraquat results in decreased expression of CCND3 mRNA | CTD | PMID:17935786 |
| parathion | multiple interactions | EXP | | 6480464 | [Parathion co-treated with Atropine] results in increased expression of CCND3 mRNA | CTD | PMID:17390078 |
| parathion | increases expression | EXP | | 6480464 | Parathion results in increased expression of CCND3 mRNA | CTD | PMID:17390078 PMID:17622325 |
| pentobarbital | decreases expression | ISO | RGD:2293 | 6480464 | Pentobarbital results in decreased expression of CCND3 protein | CTD | PMID:19346066 |
| perfluorooctane-1-sulfonic acid | increases expression | ISO | RGD:2293 | 6480464 | perfluorooctane sulfonic acid results in increased expression of CCND3 mRNA | CTD | PMID:18692542 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:2293 | 6480464 | perfluorooctanoic acid results in decreased expression of CCND3 mRNA | CTD | PMID:19162173 |
| phenylephrine | increases expression | ISO | RGD:2293 | 6480464 | Phenylephrine results in increased expression of CCND3 protein | CTD | PMID:12163013 |
| phenylephrine | multiple interactions | ISO | RGD:2293 | 6480464 | PD 98059 inhibits the reaction [Phenylephrine results in increased expression of CCND3 protein]; more ... | CTD | PMID:12163013 |
| phorbol 13-acetate 12-myristate | increases expression | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of CCND3 protein | CTD | PMID:12421932 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCND3 protein]; more ... | CTD | PMID:12421932 |
| pioglitazone | decreases expression | EXP | | 6480464 | pioglitazone results in decreased expression of CCND3 protein | CTD | PMID:15729575 |
| pirinixic acid | increases expression | ISO | RGD:733443 | 6480464 | pirinixic acid results in increased expression of CCND3 mRNA | CTD | PMID:18301758 PMID:19176532 |
| pirinixic acid | increases expression | ISO | RGD:733443 | 6480464 | pirinixic acid results in increased expression of CCND3 mRNA | CTD | PMID:19176532 PMID:18301758 |
| pirinixic acid | multiple interactions | ISO | RGD:733443 | 6480464 | RXRA protein promotes the reaction [pirinixic acid results in increased expression of CCND3 protein]; more ... | CTD | PMID:19176532 |
| pirinixic acid | increases expression | ISO | RGD:733443 | 6480464 | pirinixic acid results in increased expression of CCND3 protein | CTD | PMID:19176532 |
| piroxicam | decreases expression | EXP | | 6480464 | Piroxicam results in decreased expression of CCND3 mRNA | CTD | PMID:21858171 |
| progesterone | increases expression | ISO | RGD:2293 | 6480464 | Progesterone results in increased expression of CCND3 mRNA | CTD | PMID:17170212 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of CCND3 mRNA | CTD | PMID:14715546 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CCND3 protein | CTD | PMID:18089832 |
| resveratrol | decreases expression | ISO | RGD:2293 | 6480464 | resveratrol results in decreased expression of CCND3 protein | CTD | PMID:22104698 |
| rosiglitazone | decreases expression | EXP | | 6480464 | rosiglitazone results in decreased expression of CCND3 protein | CTD | PMID:15729575 |
| sirolimus | multiple interactions | EXP | | 6480464 | Sirolimus inhibits the reaction [IL2 protein results in increased expression of CCND3 mRNA]; more ... | CTD | PMID:15778701 |
| sirolimus | decreases expression | EXP | | 6480464 | Sirolimus results in decreased expression of CCND3 protein | CTD | PMID:12393642 more ... |
| sirolimus | decreases expression | EXP | | 6480464 | Sirolimus results in decreased expression of CCND3 protein | CTD | PMID:15882288 more ... |
| sirolimus | decreases expression | EXP | | 6480464 | Sirolimus results in decreased expression of CCND3 protein | CTD | PMID:15070696 more ... |
| sirolimus | decreases expression | EXP | | 6480464 | Sirolimus results in decreased expression of CCND3 mRNA | CTD | PMID:15882288 |
| sirolimus | decreases expression | EXP | | 6480464 | Sirolimus results in decreased expression of CCND3 protein | CTD | PMID:12393642 more ... |
| sirolimus | decreases stability | EXP | | 6480464 | Sirolimus results in decreased stability of CCND3 mRNA | CTD | PMID:15882288 |
| sirolimus | multiple interactions | ISO | RGD:733443 | 6480464 | Sirolimus inhibits the reaction [KITL protein results in increased expression of CCND3 protein] | CTD | PMID:10849422 |
| tamoxifen | affects expression | ISO | RGD:733443 | 6480464 | Tamoxifen affects the expression of CCND3 mRNA | CTD | PMID:17555576 |
| tamoxifen | multiple interactions | ISO | RGD:733443 | 6480464 | Tamoxifen inhibits the reaction [Estradiol affects the expression of CCND3 mRNA] | CTD | PMID:9094091 |
| tocopherol | decreases expression | EXP | | 6480464 | Tocopherols results in decreased expression of CCND3 protein | CTD | PMID:12504091 |
| tolbutamide | increases expression | ISO | RGD:2293 | 6480464 | Tolbutamide results in increased expression of CCND3 protein | CTD | PMID:16718685 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CCND3 protein | CTD | PMID:18089832 |
| trans-resveratrol | decreases expression | ISO | RGD:2293 | 6480464 | resveratrol results in decreased expression of CCND3 protein | CTD | PMID:22104698 |
| trichloroethene | multiple interactions | ISO | RGD:733443 | 6480464 | PPARA protein inhibits the reaction [Trichloroethylene results in increased expression of CCND3 protein] | CTD | PMID:15363585 |
| trichloroethene | increases expression | ISO | RGD:733443 | 6480464 | Trichloroethylene results in increased expression of CCND3 mRNA | CTD | PMID:15363585 |
| trichostatin A | multiple interactions | EXP | | 6480464 | trichostatin A results in increased expression of and results in increased stability of CCND3 protein | CTD | PMID:15179185 |
| troglitazone | multiple interactions | EXP | | 6480464 | Aspirin promotes the reaction [troglitazone results in decreased expression of CCND3 protein]; more ... | CTD | PMID:19908241 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of CCND3 protein | CTD | PMID:15729575 PMID:19908241 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of CCND3 protein | CTD | PMID:19908241 PMID:15729575 |
| ursodeoxycholic acid | decreases expression | EXP | | 6480464 | Ursodeoxycholic Acid results in decreased expression of CCND3 protein | CTD | PMID:17461466 |
| wortmannin | affects localization | ISO | RGD:733443 | 6480464 | wortmannin affects the localization of CCND3 protein | CTD | PMID:17129604 |
| wortmannin | multiple interactions | ISO | RGD:733443 | 6480464 | [wortmannin co-treated with imatinib] affects the localization of CCND3 protein | CTD | PMID:17129604 |
| wortmannin | multiple interactions | ISO | RGD:733443 | 6480464 | wortmannin inhibits the reaction [KITL protein results in increased expression of CCND3 protein] | CTD | PMID:10849422 |
| zoledronic acid | multiple interactions | ISO | RGD:733443 | 6480464 | [zoledronic acid co-treated with Doxorubicin] results in decreased expression of CCND3 protein | CTD | PMID:19789217 |
| zoledronic acid | decreases expression | ISO | RGD:733443 | 6480464 | zoledronic acid results in decreased expression of CCND3 protein | CTD | PMID:19789217 |